What seems odd is that he has picked up from the PACE follow up that there was no long term benefit yet that is not how the paper he quotes...
This looks like a muddled review by a junior doctor who has not himself quite worked out what he wants to say. It mentions some of the issues...
He interviewed me when we got the results on rituximab in RA. He seemed to have no interest in science whatever. Mostly in free lunches.
@Awol, I very much agree that IiME have made a huge contribution to the field. But I based what I had said on facts, not opinions or assumptions....
It seems that I am damned if I do and damned if I don't. I tried very hard to help IiME with research strategy. Unfortunately I think they have...
I have facts at my disposal that I would prefer not to have to air here. I don't want to name names of people who have been treated badly in my...
I agree that for multiple small effect genes these might not make it to the ten best bets. However, I am a bit sceptical about lots of small...
I actually think the problem is more serious than this, @Andy. It may sound crazy but recruiting people who join support groups may just end up...
I don't really buy this, Simon. Obviously the bigger any study the better but I see no problem with making use of the current study as a primer to...
Absolutely possible. Rather than doing a huge study next I would pick the ten most correlated mutations, regardless of whether or not they reach...
I think the statement is based on other research - probably studies of monozygotic and dizygotic twins, which can be used to give an approximate...
Actually it is more extreme than that. The paradigm of genetic searching in unravelling disease is ankylosing spondylitis. Around 1974 Bluestone's...
Separate names with a comma.
